Psoriasis

Psoriasis QI Pods 18th May 2021

Date: 18th May 2021

Cost: Free

Webinar 19:45 - 21:30

This promotional psoriasis programme including educational resources, virtual workshops and implementation resources has been developed by Soar Beyond and LEO Pharma. The programme is fully funded by LEO Pharma and is intended for UK Healthcare Professionals only.

The intended audience is clinical pharmacists working in general practice wanting to set up and deliver a psoriasis review clinic. This training is to be used as a guide only and should be used to augment local guidelines and pathways. Pharmacists are encouraged to link with a GP prescribing / dermatology lead for supervision and mentorship to support clinical competence. Please note that the scope of the Soar Beyond i2i resources is for psoriasis only and it is not advisable that non-specialists manage other types of dermatological conditions.

Treatment options will be discussed as part of this programme. Treatment options will be discussed at the meeting, Enstilar® (calcipotriol/betamethasone dipropionate) and Dovobet® (calcipotriol/betamethasone dipropionate) Gel and Ointment Prescribing information and adverse reporting can be found here.

Reporting of Suspected Adverse Reactions

Adverse events should be reported.

Reporting forms and information can be found at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.

Adverse events should also be reported to Drug Safety at LEO Pharma by calling +44 (0)1844 347333 or e-mail: [email protected]

Click here to report an adverse event

MAT-40174 V4

Date of preparation : April 2021

Speakers

Dominika Froehlich-Jeziorek

Dominika is a senior pharmacist and a pharmacy team lead at Fernbank Surgery in Lytham, Lancashire. She has extensive experience across community pharmacy, medicines management and primary care, including care homes. Her clinical interests are focused on the management of respiratory diseases, chronic pain and dermatological conditions.

Read Bio
Dianne Sanderson

Dianne is an independent prescriber working as a senior clinical pharmacist within a GP practice and a mentor to other pharmacists within the PCN. Dianne also works as a dermatology pharmacist within a community based specialist dermatology service.

 

Read Bio

Agenda

By participating in this interactive QI pod, you will:

  1. Be coached by role model GP Pharmacists Dianne Sanderson and Dominika Froehlich-Jeziorek to think through your practical QI implementation process
  2. Have the opportunity to breakout into smaller groups to discuss best practice as well as anticipated challenges you face implementing your QI process to the practice
  3. Consider and design effective evaluation criteria for your psoriasis patients including use of DLQI for your psoriasis annual reviews and structured medication reviews (SMRs)
  4. Leave with a clear personalised QI action plan to help you implement at practice level and keep you accountable

Supported by

sponsor

This promotional psoriasis programme including educational resources, virtual workshops and implementation resources has been developed by Soar Beyond and LEO Pharma. The programme is fully funded by LEO Pharma and is intended for UK Healthcare Professionals only.

The intended audience is clinical pharmacists working in general practice wanting to set up and deliver a psoriasis review clinic. This training is to be used as a guide only and should be used to augment local guidelines and pathways. Pharmacists are encouraged to link with a GP prescribing / dermatology lead for supervision and mentorship to support clinical competence. Please note that the scope of the Soar Beyond i2i resources is for psoriasis only and it is not advisable that non-specialists manage other types of dermatological conditions.

Treatment options will be discussed as part of this programme. Treatment options will be discussed at the meeting, Enstilar® (calcipotriol/betamethasone diproprionate) and Dovobet® (calcipotriol/betamethasone diproprionate) Gel and Ointment Prescribing information and adverse reporting can be found here.

Reporting of Suspected Adverse Reactions

Adverse events should be reported.

Reporting forms and information can be found at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.

Adverse events should also be reported to Drug Safety at LEO Pharma by calling +44 (0)1844 347333 or e-mail: [email protected]

Click here to report an adverse event

MAT-40174 V3

Date of preparation : April 2021

Hide

Health Care Professionals Attend An Event

Book onto an event as a healthcare professional
  • All communication will be received through this email.
  • This field is for validation purposes and should be left unchanged.